What you need to know about Australia’s new Smart Energy Council
A new energy industry organisation, the Smart Energy Council has been formed, a body which will push the agenda for cleaner, smarter energy solutions nationwide.
It combines the expertise of the Australian Solar Council and the Energy Storage Council into one streamlined association, describing itself as the new national voice for Australia’s smart energy future.
Chief Executive John Grimes said: “Australia will inevitably be powered by Smart Energy. We represent the most innovative renewable energy leaders in the field. We are transforming to better reflect our members and Australia’s energy future.
“We have been enormously successful in the past, and will continue to work with our members to support Australia’s Smart Energy transition. Australia has the world’s best solar scientists, the world’s highest uptake of household solar, and is a world leader in energy storage.”
- Edify completes funding for solar projects following investment from BlackRock
- First Solar contracted for Australia’s biggest solar project
- Read the latest issue of Business Review Australia here
While this may be a new organisation, its origins trace back to 1954 with the formation of the Australian Solar Council, with the Energy Storage Council being founded in 2014. Members of both bodies will see their memberships transition into the new association.
Grimes says that consumers are ready to join them in pressing for a renewable future. He added: “Almost 4mn Australian homes have solar on their rooftops. Over 6,000MW of solar photovoltaics have been installed, and this number continues to grow. That’s because Australians know solar works. Solar saves money. Solar is the cheapest way to generate new electricity, bar none.
“Australians want cheap, reliable, clean energy because they know it’s the smart choice. They want tailored solutions that match supply and demand in the most efficient and cleanest way. They want control of their energy. They want to produce and store their own energy. They want smart energy management systems that do the work for them.”
Seo JungJin: Who is EY’s World Entrepreneur of 2021?
Seo JungJin, founder of biopharma firm Celltrion, which most recently developed an antibody treatment for COVID-19, has been named the EY World Entrepreneur of the Year 2021, becoming the first South Korean in the award’s 21-year history.
Regarded as one of the world’s most prestigious business awards program for entrepreneurs, the EY Entrepreneur of the Year celebrates visionary and innovative leaders from across 60 countries who are transforming the world and fostering growth.
JungJin, who is now honoroary chairman of Celltrion Group, was up against a worthy cast of entrepreneurial competitors, taking the crown from among 45 award winners across 38 countries and territories.
Speaking during the virtual event, JungJin described his own interpretation of entrepreneurship as something that brings together “a group of people toward a common vision, embracing challenges as opportunities and committing oneself to contribute to the greater good”.
Why was JungJin crowned King Entrepreneur?
A South Korean native and now 63 years of age, JungJin founded biopharmaceutical firm Celltrion in 2003. In the nearly two decades since its founding, Celltrion has lived up to its goal of advancing health and welfare for all by developing ground-breaking drugs to treat autoimmune disease, various forms of cancer and, most recently, COVID-19.
The company, which JungJin started with just US$45,000 and five of his colleagues, has since growth to more than 2,1000 employees with sales permits in more than 90 countries and revenues exceeding US$1.69bn.
According to the panel, JungJin’s story is a shining example of the power of an unstoppable entrepreneur to change the world with the pandel moved by both his incredible story and his purpose-driven leadership, innovative mindset and entrepreneurial spirit.
Described by the chair of the EY judging panel Rosaleen Blair as “representing everything an unstoppable should be” from taking on the world’s biggest health care challenges to consistently creating long-term value for his company, JungJin’s story is one of incredible tenacity and perseverance that the judging panel felt most represented the entrepreneurial spirit.
“He’s taken breathtaking risks, both personal and professional, to found Celltrion and grow it into one of the world’s leading biopharmaceutical companies,” says Stasia Mitchell, EY Global Entrepreneurship Leader. “His passion for creating affordable, life-saving health care and flair for tackling global problems has led to many treatments that have helped millions of people worldwide and was especially evident this past year through the creation of a COVID-19 antibody treatment.”
How did JungJin get there?
JungJin's entrepreneurial journey started at an early age when he worked as a taxi driver to get himself through Konkuk University in Seoul, South Korea. After studying industrial engineering, he rose through the ranks of Daewoo Motor Co. before losing his job amid the carmaker’s financial troubles following the 1997 Asian economic crisis.
Following this, JungJin started collaborating with colleagues to explore business opportunities in different industries, though none delivered lasting success. The turning point came after he attended a talk hosted by renowned scholars, which inspired him to focus on the biopharmaceutical sector.
And so he founded Celltrion with just US$45,000 of his savings. The launch of Remsima, credited with being the world's first antibody biosimilar, quickly moved Celltrion up the ranks of the country's fairly underdeveloped pharmaceutical sector. Celltrion followed this success with the launch of drugs for breast cancer and lymphoma that today are being used worldwide.
With ambitions to be the world’s first in different areas, Celltrion has pioneered numerous uncharted areas to great success over the past two decades, most recently responding to the global pandemic by successfully developing an antibody treatment for COVID-19 and working to ensure a timely supply of the safe and effective treatment.
“When I first started, my vision was to help patients gain access to safe, effective and affordable medicines and thereby enhance the quality of people’s lives,” explains JungJin. “The success of Celltrion has enabled me to expand on this while finding new ways to fuel my entrepreneurial drive.”